Skip to content

Clinical trials

Phase 1 Melanoma trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Melanoma Phase: Phase 1 Country / region: United Kingdom Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20082
20102
20112
20134
20153
20172
20181
20192
20204
20212
20224
20232
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Terminated9
Active, not recruiting5
Unknown status3
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer3
GlaxoSmithKline2
Seagen Inc.2
ADC Therapeutics S.A.1
Antisoma Research1
AstraZeneca1
BerGenBio ASA1
C4 Therapeutics, Inc.1
Deciphera Pharmaceuticals, LLC1
EMD Serono Research & Development Institute, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Melanoma34
Carcinoma, Non-Small-Cell Lung15
Colorectal Neoplasms7
Neoplasms7
Carcinoma, Renal Cell6
Pancreatic Neoplasms6
Triple Negative Breast Neoplasms6
Urinary Bladder Neoplasms6
Breast Neoplasms5
Ovarian Neoplasms5

Trials

Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.